These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 149924)

  • 1. Use of the spot, plate and suspension test systems for the detection of the mutagenicity of environmental agents and chemical carcinogens in Neurospora crassa.
    Ong TM
    Mutat Res; 1978 Jun; 53(3):297-308. PubMed ID: 149924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the cytotoxic and mutagenic effects of selected mutagens on excision repair-sufficient and -deficient AD-3 mutants of Neurospora crassa.
    Ong T; Converse JO
    Mutat Res; 1983 Oct; 124(1):61-7. PubMed ID: 6226873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic characterization of the mutagenic activity of environmental chemicals at specific loci in two-component heterokaryons of Neurospora crassa.
    de Serres FJ; Brockman HE
    Prog Clin Biol Res; 1986; 209A():209-18. PubMed ID: 2944123
    [No Abstract]   [Full Text] [Related]  

  • 4. Mutagenicity and mutagenic specificity of metronidazole and niridazole in Neurospora crassa.
    Ong T; Slade B; de Serres FJ
    J Environ Pathol Toxicol; 1979; 2(4):1109-18. PubMed ID: 156240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutagenicity and mutagenic specificity of metronidazole and niridazole in Neurospora crassa.
    Ong T; Slade B
    J Toxicol Environ Health; 1978; 4(5-6):815-24. PubMed ID: 153406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tests for the genotoxicity of m-AMSA, etoposide, teniposide and ellipticine in Neurospora crassa.
    Gupta R
    Mutat Res; 1990 Feb; 240(2):47-58. PubMed ID: 2137196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and classical genetic analyses of his-3 mutants of Neurospora crassa. I. Tests for allelic complementation and specific revertibility.
    Overton LK; Dubins JS; de Serres FJ
    Mutat Res; 1989 Oct; 214(2):267-83. PubMed ID: 2529437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the uvs-2 allele of Neurospora crassa on the mutagenic potency of two N-hydroxylaminopurines and 2-aminopurine in the ad-3 forward-mutation test.
    Brockman HE; de Serres FJ; Hung CY; Ong T
    Mutat Res; 1989 Jul; 218(1):1-11. PubMed ID: 2526296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of Neurospora in detecting agents that cause aneuploidy.
    Griffiths AJ; Brockman HE; DeMarini DM; de Serres FJ
    Mutat Res; 1986; 167(1-2):35-45. PubMed ID: 2934630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of pH on the mutagenicity of sodium azide in Neurospora crassa and Salmonella typhimurium.
    Tomlinson CR
    Mutat Res; 1980 Apr; 70(2):179-91. PubMed ID: 6445502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic analysis of ad-3 mutants induced by AF-2 and two other nitrofurans in Neurospora crassa.
    Ong T; de Serres FJ
    Environ Mutagen; 1981; 3(2):151-8. PubMed ID: 6165577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two N-hydroxylaminopurines are highly mutagenic in the ad-3 forward-mutation test in growing cultures of heterokaryon 12 of Neurospora crassa.
    Brockman HE; de Serres FJ; Ong TM; Hung CY
    Mutat Res; 1987 Mar; 177(1):61-75. PubMed ID: 2950320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the mutagenicity and mutagen specificity of ethylenimine with triethylenemelamine in the ad-3 region of heterokaryon 12 of Neurospora crassa.
    de Serres FJ; Malling HV; Ong TM
    Mutat Res; 1995 May; 328(2):193-205. PubMed ID: 7739603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative and qualitative comparison of spontaneous and chemical-induced specific-locus mutation in the ad-3 region of heterokaryon 12 of Neurospora crassa.
    de Serres FJ; Malling HV; Brockman HE; Ong TM
    Mutat Res; 1997 Apr; 375(1):53-72. PubMed ID: 9129679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simplified method for the simultaneous detection of intragenic and intergenic mutations (deletions) in Neurospora crassa.
    Luker MA; Kilbey BJ
    Mutat Res; 1982 Feb; 92(1-2):63-8. PubMed ID: 6211615
    [No Abstract]   [Full Text] [Related]  

  • 16. Ethylene oxide: induction of specific-locus mutations in the ad-3 region of heterokaryon 12 of Neurospora crassa and implications for genetic risk assessment of human exposure in the workplace.
    de Serres FJ; Brockman HE
    Mutat Res; 1995 Apr; 328(1):31-47. PubMed ID: 7898502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of Neurospora in the evaluation of the mutagenic activity of environmental chemicals.
    de Serres FJ
    Environ Mutagen; 1983; 5(3):341-51. PubMed ID: 6221926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation-induction in repair-deficient strains of Neurospora.
    de Serres FJ
    Basic Life Sci; 1980; 15():75-84. PubMed ID: 6452121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic characterization of diethylnitrosamine-induced purple adenine (ad-3) mutants in Neurospora crassa.
    Malling HV; De Serres FJ
    Cancer Res; 1972 Jun; 32(6):1273-7. PubMed ID: 4260579
    [No Abstract]   [Full Text] [Related]  

  • 20. Utilization of the specific-locus assay in the ad-3 region of two-component heterokaryons of Neurospora for risk assessment of environmental chemicals.
    de Serres FJ
    Mutat Res; 1991; 250(1-2):251-74. PubMed ID: 1834935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.